Sahar Mahdawi-Al
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
A new FRDA mouse model [Fxn null:YG8s(GAA) > 800] with more than 800 GAA repeats.
Journal: Frontiers in neuroscience
Published: April 27, 2022
A Drug Combination Rescues Frataxin-Dependent Neural and Cardiac Pathophysiology in FA Models.
Journal: Frontiers in molecular biosciences
Published: December 07, 2021
HMTase Inhibitors as a Potential Epigenetic-Based Therapeutic Approach for Friedreich's Ataxia.
Journal: Frontiers in genetics
Published: December 03, 2019
Large Interruptions of GAA Repeat Expansion Mutations in Friedreich Ataxia Are Very Rare.
Journal: Frontiers in cellular neuroscience
Published: July 26, 2018
FAST-1 antisense RNA epigenetically alters FXN expression.
Journal: Scientific reports
Published: July 23, 2018
Effect of diazoxide on Friedreich ataxia models.
Journal: Human molecular genetics
Published: September 24, 2017
Lentivirus-meditated frataxin gene delivery reverses genome instability in Friedreich ataxia patient and mouse model fibroblasts.
Journal: Gene therapy
Published: October 14, 2015
A novel GAA-repeat-expansion-based mouse model of Friedreich's ataxia.
Journal: Disease models & mechanisms
Published: February 15, 2015
Identification of telomere dysfunction in Friedreich ataxia.
Journal: Molecular neurodegeneration
Published: October 31, 2014
The emerging role of 5-hydroxymethylcytosine in neurodegenerative diseases.
Journal: Frontiers in neuroscience
Published: October 01, 2014
Epigenetic-based therapies for Friedreich ataxia.
Journal: Frontiers in genetics
Published: April 01, 2014
Last Updated: 09/26/2026